FS KKR Capital Corp.
NYSE:FSKAsset Management
+$0.12 today
- Market cap
- $3.04B
- Beta
- 0.90
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.96
- Dividend yield
- 22.24%
Volume 2.07M
Average 3.50M
FSK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
FS KKR Capital Corp.NYSE: FSK
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How FSK compares with its peers on the latest reported figures
- FSK's LTM Sep 2026 research & development of $0 is the highest of the 15 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for FSK, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Dec 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding FSK) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for FSK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.77B | 463M | 1.23B | 1.11B | 1.17B |
| Cost of Revenue | 222M | 351M | 451M | 446M | 356M |
| Gross Profit | 1.54B | 112M | 779M | 664M | 815M |
| Gross Margin | 87.4% | 24.2% | 63.3% | 59.8% | 69.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34M | 42M | 42M | 37M | 0 |
| Operating Expenses | 16M | (4M) | 58M | 56M | 235M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 24M |
| EBITDA | 1.53B | 116M | 721M | 608M | 511M |
| EBITDA Margin | 86.5% | 25.1% | 58.6% | 54.8% | 43.6% |
| Operating Income | 1.53B | 116M | 721M | 608M | 580M |
| Operating Margin | 86.5% | 25.1% | 58.6% | 54.8% | 49.5% |
| Interest Income | 794M | 1.27B | 1.49B | 1.38B | 1.48B |
| Interest Expense | 222M | 351M | 451M | 446M | 464M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (557M) |
| Income Before Tax | 1.53B | 116M | 721M | 608M | 23M |
| Pre-Tax Margin | 86.5% | 25.1% | 58.6% | 54.8% | 2.0% |
| Income Tax Expense | 12M | 24M | 25M | 23M | 12M |
| Net Income | 1.52B | 92M | 696M | 585M | 11M |
| Net Margin | 85.8% | 19.9% | 56.6% | 52.7% | 0.9% |
| EPS (Basic) | 7.16 | 0.32 | 2.48 | 2.09 | 0.04 |
| EPS (Diluted) | 7.16 | 0.32 | 2.48 | 2.09 | 0.04 |
| Weighted Avg Shares | 211.67M | 283.51M | 280.28M | 280.07M | 280.07M |
| Weighted Avg Shares (Diluted) | 211.67M | 283.51M | 280.28M | 280.07M | 280.07M |
FS KKR Capital Corp.
NYSE:FSK
Intrinsic Alpha fair value
Locked
Current Price
$11.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.